Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review.

CONTEXT There has not been a comprehensive compilation of data regarding the epidemiology of all endocrine and metabolic disorders in the United States. EVIDENCE ACQUISITION We included 54 disorders with clinical and public health significance. We identified population-based studies that provided U.S. prevalence and/or incidence data by searching PubMed in December 2007 for English-language reports, hand-searching reference lists of six textbooks of endocrinology, obtaining additional resources from identified experts in each subspecialty, and searching epidemiological databases and web sites of relevant organizations. When available, we selected articles with data from 1998 or later. Otherwise, we selected the article with the most recent data, broadest geographical coverage, and most stratifications by sex, ethnicity, and/or age. Ultimately, we abstracted data from 70 articles and 40 cohorts. EVIDENCE SYNTHESIS Endocrine disorders with U.S. prevalence estimates of at least 5% in adults included diabetes mellitus, impaired fasting glucose, impaired glucose tolerance, obesity, metabolic syndrome, osteoporosis, osteopenia, mild-moderate hypovitaminosis D, erectile dysfunction, dyslipidemia, and thyroiditis. Erectile dysfunction and osteopenia/osteoporosis had the highest incidence in males and females, respectively. The least prevalent conditions, affecting less than 1% of the U.S. population, were diabetes mellitus in children and pituitary adenoma. Conditions with the lowest incidence were adrenocortical carcinoma, pheochromocytoma, and pituitary adenomas. Certain disorders, such as hyperparathyroidism and thyroid disorders, were more common in females. As expected, the prevalence of diabetes mellitus was highest among ethnic minorities. Sparse data were available on pituitary, adrenal, and gonadal disorders. CONCLUSIONS The current review shows high prevalence and incidence of common endocrine and metabolic disorders. Defining the epidemiology of these conditions will provide clues to risk factors and identify areas to allocate public health and research resources.

[1]  A. Elster,et al.  Clinically serious abnormalities found incidentally at MR imaging of the brain: data from the Cardiovascular Health Study. , 1997, Radiology.

[2]  G. Huster,et al.  Hormonal studies and physical maturation in adolescent gynecomastia. , 1990, The Journal of pediatrics.

[3]  L. Melton,et al.  Long-term trends in the incidence of Paget's disease of bone. , 2000, Bone.

[4]  E. Barrett-Connor,et al.  Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. , 2001, JAMA.

[5]  W. Murphy,et al.  Prevalence of Pelvic Paget's Disease of Bone in the United States , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  Gardner.  Greenspan\'s Basic And Clinical Endocrinology , 2007 .

[7]  G. Curhan,et al.  Time trends in reported prevalence of kidney stones in the United States: 1976-1994. , 2003, Kidney international.

[8]  Desmond E. Williams,et al.  The Burden of Diabetes Mellitus Among US Youth: Prevalence Estimates From the SEARCH for Diabetes in Youth Study , 2006, Pediatrics.

[9]  Robert L Hanson,et al.  Components of the "metabolic syndrome" and incidence of type 2 diabetes. , 2002, Diabetes.

[10]  J. Manson,et al.  Smoking and other lifestyle factors and the risk of Graves' hyperthyroidism. , 2005, Archives of internal medicine.

[11]  R. Hamman,et al.  Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. , 2005, Diabetes care.

[12]  S. Guttmacher,et al.  Bone Health of Immigrant Chinese Women Living in New York City , 2006, Journal of Community Health.

[13]  N. Binkley,et al.  Low bone mass prevalence and osteoporosis risk factor assessment in African American Wisconsin women. , 2005, WMJ : official publication of the State Medical Society of Wisconsin.

[14]  Christina Wang,et al.  Validation of a testosterone and dihydrotestosterone liquid chromatography tandem mass spectrometry assay: Interference and comparison with established methods , 2008, Steroids.

[15]  S. Nussey,et al.  Endocrinology: An Integrated Approach , 2001 .

[16]  C. Lewis,et al.  A 20-Year Prospective Study of Childbearing and Incidence of Diabetes in Young Women, Controlling for Glycemia Before Conception , 2007, Diabetes.

[17]  R. Klein,et al.  Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. , 2004, Ophthalmology.

[18]  A. Araujo,et al.  Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. , 2000, The Journal of urology.

[19]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[20]  L. Melton,et al.  Long-term trends in thyroid carcinoma: a population-based study in Olmsted County, Minnesota, 1935-1999. , 2005, Mayo Clinic proceedings.

[21]  Louise Davies,et al.  Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.

[22]  A. Fagot-Campagna,et al.  Establishing surveillance for diabetes in American Indian youth. , 2001, Diabetes care.

[23]  R. Williams,et al.  Williams Textbook of endocrinology , 1985 .

[24]  Michael M. Engelgau,et al.  Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population , 2006, Diabetes Care.

[25]  Ricardo Azziz,et al.  0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected , 2022 .

[26]  Michael J. Pencina,et al.  Trends in the Incidence of Type 2 Diabetes Mellitus From the 1970s to the 1990s: The Framingham Heart Study , 2006, Circulation.

[27]  D. Baldwin,et al.  Incidence of thyroid disorders in Connecticut. , 1978, JAMA.

[28]  W. J. Litchy,et al.  The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort , 1993, Neurology.

[29]  K. Noller,et al.  Natural history of premature thelarche in Olmsted County, Minnesota, 1940 to 1984. , 1990, The Journal of pediatrics.

[30]  E. Boyko,et al.  Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. , 2000, Diabetes care.

[31]  L. Kurland,et al.  Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. , 1983, Mayo Clinic proceedings.

[32]  S. Helgerson,et al.  Prevalence and Risk Factors for Diabetes and Diabetes-Related Amputations in American Indians In Southern Arizona , 1993, Diabetes Care.

[33]  Sundeep Khosla,et al.  Incidence of Primary Hyperparathyroidism in Rochester, Minnesota, 1993–2001: An Update on the Changing Epidemiology of the Disease , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  M. Engelgau,et al.  Prevalence of Impaired Fasting Glucose and Its Relationship With Cardiovascular Disease Risk Factors in US Adolescents, 1999–2000 , 2005, Pediatrics.

[35]  L. Demers.  Testosterone and estradiol assays: Current and future trends , 2008, Steroids.

[36]  H. Wahner,et al.  Subacute (granulomatous) thyroiditis in Olmsted County, Minnesota. , 1970, Mayo Clinic proceedings.

[37]  T. Wilt,et al.  Predictors and prevalence of erectile dysfunction in a racially diverse population. , 2006, Archives of internal medicine.

[38]  S. Jacobsen,et al.  The incidence of Graves' ophthalmopathy in Olmsted County, Minnesota. , 1995, American journal of ophthalmology.

[39]  K. Flegal,et al.  Prevalence of overweight and obesity in the United States, 1999-2004. , 2006, JAMA.

[40]  R. Roberts,et al.  Postpartum lymphocytic thyroiditis. Prevalence, clinical course, and long-term follow-up. , 1987, Archives of internal medicine.

[41]  B. Munoz,et al.  Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. , 2001, Diabetes care.

[42]  D. Harris,et al.  Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. , 1994, The Journal of pediatrics.

[43]  L. Geiss,et al.  Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. , 2003, Diabetes care.

[44]  E. Ford,et al.  Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. , 2005, Diabetes care.

[45]  G. Lip,et al.  Secular trends in cardiovascular disease , 2002, Journal of Human Hypertension.

[46]  Electron Kebebew,et al.  Extent of Disease at Presentation and Outcome for Adrenocortical Carcinoma: Have We Made Progress? , 2006, World Journal of Surgery.

[47]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[48]  L. Kuller,et al.  Diabetes, Hyperglycemia, and Inflammation in Older Individuals , 2006, Diabetes Care.

[49]  A. Dobs,et al.  Androgen deficiency, diabetes, and the metabolic syndrome in men , 2007, Current opinion in endocrinology, diabetes, and obesity.

[50]  Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. , 1999, Neuro-oncology.

[51]  M S Calvo,et al.  Prevalence of Low Femoral Bone Density in Older U.S. Adults from NHANES III , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[52]  L. Kuller,et al.  Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. , 2001, Diabetes care.

[53]  R. Klein,et al.  Diabetic retinopathy in a multi-ethnic cohort in the United States. , 2006, American journal of ophthalmology.

[54]  Keith C. Norris,et al.  The prevalence of hypovitaminosis D among US adults: data from the NHANES III. , 2005, Ethnicity & disease.

[55]  L. Melton,et al.  Incidence and clinical spectrum of thiazide-associated hypercalcemia. , 2007, The American journal of medicine.

[56]  K. Flegal,et al.  Secular trends in cardiovascular disease risk factors according to body mass index in US adults. , 2005, JAMA.

[57]  W. Willett,et al.  Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. , 2004, Archives of internal medicine.

[58]  Daniel L. McGee,et al.  Obesity, very low density lipoproteins, and glucose intolerance over fourteen years: The Framingham Study. , 1981, American journal of epidemiology.

[59]  A. Ferrara,et al.  An Increase in the Incidence of Gestational Diabetes Mellitus: Northern California, 1991–2000 , 2004, Obstetrics and gynecology.

[60]  A. Meikle,et al.  Natural history of thyroid abnormalities: prevalence, incidence, and regression of thyroid diseases in adolescents and young adults. , 1991, The American journal of medicine.

[61]  Dana Dabelea,et al.  Incidence of diabetes in youth in the United States. , 2007, JAMA.

[62]  A model to determine workforce needs for endocrinologists in the United States until 2020. , 2003, Diabetes care.

[63]  T. Orchard,et al.  Cardiovascular autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes. Incidence and predictors. , 2000, Journal of diabetes and its complications.

[64]  I. Modlin,et al.  A 5‐decade analysis of 13,715 carcinoid tumors , 2003, Cancer.

[65]  Desmond E. Williams,et al.  Peripheral insensate neuropathy--a tall problem for US adults? , 2006, American journal of epidemiology.

[66]  E. Rimm,et al.  Sexual Function in Men Older Than 50 Years of Age: Results from the Health Professionals Follow-up Study , 2003, Annals of Internal Medicine.

[67]  R. Vasan,et al.  The impact of assay quality and reference ranges on clinical decision making in the diagnosis of androgen disorders , 2008, Steroids.

[68]  Diabetes trends among American Indians and Alaska natives: 1990-1998. , 2001, Diabetes care.

[69]  W Harry Hannon,et al.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). , 2002, The Journal of clinical endocrinology and metabolism.

[70]  A. Folsom,et al.  Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. , 2000, JAMA.

[71]  S. Arver,et al.  The triad of erectile dysfunction, hypogonadism and the metabolic syndrome , 2008, International journal of clinical practice.

[72]  P. Wahl,et al.  Prevalence of Diabetes Mellitus and Impaired Glucose Tolerance Among Second-Generation Japanese-American Men , 1987, Diabetes.

[73]  M. Tzanela.  Adult growth hormone deficiency: to treat or not to treat , 2007, Expert opinion on pharmacotherapy.

[74]  T. Frieden,et al.  Trends and racial/ethnic disparities in gestational diabetes among pregnant women in New York City, 1990-2001. , 2005, American journal of public health.